MediWound (NASDAQ:MDWD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback